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ABSTRACT 
OBJECTIVE: The divergent homeobox transcription factor Hlx plays an essential role in visceral 
organogenesis in mice and has been shown to regulate angiogenic sprouting in vitro and in 
zebrafish embryos. We therefore examined the role of Hlx in vascular development in mouse 
and avian embryos.  
APPROACH AND RESULTS: In situ hybridization showed that Hlx is expressed in a subset of 
sprouting blood vessels in postnatal mouse retinas and embryos. Hlx expression was conserved 
in quail embryos and upregulated in blood vessels at the onset of circulation. In vitro assays 
showed that Hlx is dynamically regulated by growth factors and shear stress alterations. Pro-
angiogenic VEGF induces Hlx expression in cultured endothelial cells; whereas signals that 
induce stalk cell identity lead to a reduction in Hlx expression. Hlx was also downregulated in 
embryos in which flow was ablated, while injection of a starch solution, which increases blood 
viscosity and therefore shear stress, causes an upregulation in Hlx. Hlx knockdown in vitro 
resulted in a reduction in tip cell marker expression and in reduced angiogenic sprouting but   
Hlx-/- embryos showed no defect in vascular sprouting at E8.5, E9.5 or E11.5 in vivo. Vascular 
remodeling of the capillary plexus was altered in Hlx-/- embryos, with a modestly enlarged venous 
plexus and reduction of the arterial plexus.  
CONCLUSIONS: Our findings indicate that Hlx regulates sprouting in vitro but that its role in 
sprouting is non-essential in vivo. We find Hlx is regulated by shear stress and a subtle defect in 
vascular remodeling is present in knockout embryos. 
 
NON-STANDARD ABBREVIATIONS 
Ang2 - Angiopoietin-2 
Apln - Apelin 
Dll4 - Delta-like 4 
Esm1 - Endothelial cell-specific molecule 1 
Ets-1 - E26 transformation-specific 
HLX - H2.0-like homeobox transcription factor  
PDGFB - Platelet-derived growth factor B 
UNC5B - Uncoordinated 5 homolog B 
VEGF - Vascular Endothelial Growth Factor 
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INTRODUCTION 
Homeobox (Hox) genes are evolutionary conserved genes that are chromosomally 
clustered in many animal genomes 1. Hox genes encode transcription factors with a conserved 
60 amino acid DNA-binding homeodomain, and are involved in transcriptional regulation of 
eukaryotic developmental processes, particularly in directing tissue morphogenesis and 
patterning2.  
The H2.0-like homeobox transcription factor (Hlx) is a diverged, non-clustered 
homeodomain protein, with a pivotal role in visceral organogenesis and enteric nervous system 
development3-6. In mouse embryos, the highest expression of Hlx is detected in the 
mesenchyme of the developing liver and intestine4, 6. Hlx is highly conserved in its gene 
structure, expression pattern and protein sequence in 9 different species, ranging from fish to 
avians and mammals7; which implies an important evolutionary function. Indeed, deletion of the 
gene encoding Hlx in mice results in embryonic lethality at E15, with intestines that fail to 
elongate and expand likely due to defects in guidance cues in the enteric nervous system 3, 6. In 
addition to defects in intestinal growth, Hlx-/- embryos exhibit severe anemia and hypoplasia of 
the liver (3% of its normal size)4. These findings demonstrate important developmental functions 
of Hlx during visceral mesoderm growth. 
HLX is also implicated in human pathology: HLX is overexpressed in patients with acute 
myeloid leukemia (AML), which induces formation of aberrant progenitor cells with unlimited 
clonogenicity and blocked differentiation. Inhibition of HLX in leukemic cells reduces proliferation 
and clonogenicity, identifying HLX as a key regulator in immature hematopoietic and leukemia 
cells and as a prognostic marker and therapeutic target in AML8, 9. 
In endothelial cells cultured in vitro, overexpression of HLX was shown to inhibit 
endothelial cell sprouting, migration and vessel formation, without affecting proliferation. HLX 
was shown to robustly upregulate expression of repulsive cell-guidance proteins, such as 
UNC5B, Plexin-A1, and Semaphorin-3G 10. It was proposed in this context that HLX may 
function to balance attractive guidance cues (when stimulated by VEGF) with repulsive vessel 
guidance cues in order to regulate sprouting in endothelial cells 10. Additionally, in zebrafish, Hlx 
expression is confined to endothelial cells sprouting from the dorsal aorta into the intersegmental 
region, and not expressed in adjacent non-angiogenic endothelial cells. Morpholino-mediated 
knockdown of Hlx led to stunted intersegmental vessel sprouts which failed to connect with 
neighboring vessels; thus Hlx was proposed to promote/reinforce stalk cell potential in this 
context 11. These findings showed that both loss- and gain-of function of Hlx affected vessel 
sprouting, suggesting important roles of this transcription factor in vessel branching 
morphogenesis. However, previous studies using genetic loss-of-function models in mice have 
not addressed the role of Hlx in blood vessel formation. 
Here we show that endothelial cells express Hlx during development in two amniote 
models; mouse and quail embryos. The expression is not ubiquitous but labels a subset of 
endothelial cells. We then investigate the function of Hlx in angiogenic sprouting. We find that 
Hlx controls the expression of some stalk/tip cells genes and that knockdown of Hlx inhibits 
sprouting in vitro. From our time course in early vascular development, we had observed that Hlx 
expression was strongest in endothelial cells just after the onset of flow. We therefore use three 
different models to alter flow and look at Hlx regulation in response to flow. We find that shear 
stress can upregulate Hlx. We investigated whether a vascular phenotype was present in Hlx-
null embryos. We find that the intra-embryonic vasculature forms normally and that sprouting is 
normal in all tissues investigated at E8.5, E9.5 and E11.5. When we looked at the yolk sac 
vascular plexus, we found a remodeling defect:  the venous plexus is enlarged and the vitelline 
vein is enlarged, as compared to control. A proportional decrease in arterial diameter is present. 
Our results show that while Hlx can regulate sprouting in vitro, its role in vascular sprouting is 
non-essential in mouse embryos in vivo. In contrast, we find that Hlx is upregulated by flow. We 
also find that Hlx ablation affects vascular remodeling. 
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MATERIALS AND METHODS 
Materials and Methods are available as online supplemental material. 
 
RESULTS 
Hlx is dynamically regulated in developing blood vessels in mice and quail embryos  
Hlx was previously described as a gene upregulated by VEGF and suppressed by Notch 
signaling in endothelial cells in vitro and in zebrafish embryos 10, 11. Consistent with these results, 
we found that compared to wildtype controls, Hlx expression was increased (3.5 fold) in 
microarrays from Dll4+/- retinal endothelial cells, which present an excessive sprouting 
phenotype12. Furthermore, in situ hybridization with an Hlx antisense riboprobe on postnatal day 
5 (P5) mouse retinas showed Hlx expression in a subset of tip cells, confirming the microarray 
results and suggesting a possible function for Hlx in sprouting angiogenesis (Figure 1A,B, red 
and blue arrowheads).  
Examination of Hlx expression in E10.5 mouse embryos revealed strongly labeled 
splanchnopleural visceral mesoderm associated with the developing lung and liver, while sense 
probes showed no specific signal (Figure1C,D). Hlx expression was absent in the heart, as well 
as in the endothelium of the larger vascular structures such as the cardinal vein and the dorsal 
aorta (Figure 1E). Hlx expression was present in vessels branching off the aorta (Figure 1E, 
black arrowhead) and in the perineural vascular plexus (Figure 1F, arrows). Within the neural 
epithelium, we failed to detect any Hlx staining of endothelial cells (Figure1G,H, green 
arrowheads). In E12.5 embryos, Hlx expression became downregulated in the liver, but 
remained enriched in splanchnic mesoderm and was also found in the developing sclerotome 
and neural tube, with strongest expression in the roof plate (data not shown). A subset of smaller 
blood vessels remained positive for Hlx expression in the perineural vascular plexus surrounding 
the neural epithelium and in the dermis. Capillaries inside the neural epithelium however, did not 
stain positive for Hlx expression at E10.5 or E12.5. Together, these expression studies confirm 
previous reports demonstrating preferential Hlx expression in developing visceral mesoderm of 
mouse embryos 3, 4, 6, 7, 13 and show that a subset of sprouting vessels in the mouse retina and in 
the embryo, respectively, express Hlx. 
To assess Hlx expression in another developing amniotic model, we performed whole 
mount in situ analysis on developing quail embryos. Consistent with our findings in mice, we 
found Hlx to be enriched in the splanchnic mesoderm, prior to and during formation of the 
intestine and liver (Figure 2A,B). In addition to the splanchnic mesoderm, Hlx is also detected in 
the branchial arches but not in the heart (Figure 2A-B, arrowheads). In the embryo proper, Hlx 
expression was absent in endothelial cells lining the heart and the dorsal aorta, consistent with 
previous reports 7. 
We noticed a significant level of Hlx expression in the capillary plexus of the yolk sac. We 
chose 3 specific stages (8 somites, 14 somites and 20 somites) at which to look at vascular 
expression. Vascular development begins in the extra-embryonic capillary plexus at 0 to 5 
somites in quail embryos, when blood islands establish the primary components and set the 
outline of the blood vessel network. Once the initial plexus is formed de novo, the heart begins to 
beat and the plexus undergoes vascular remodeling. Erythroblasts enter the circulation between 
11-13 somites. The first morphologically distinct arteries and veins are present by approximately 
20 somites (mid-vascular remodeling stage), and the mature architecture of the vascular network 
is attained at 4 days, or Hamburger Hamilton stage 23. 
In the quail extra-embryonic region, we detected Hlx in mesodermal and endothelial cells of the 
capillary plexus at all stages investigated (Figure 2C). The expression pattern of Hlx was 
ubiquitous throughout the plexus and did not show arterial-venous specificity (data not shown). 
Sense probes did not show any specific signal (Figure 2D). To quantify Hlx expression levels in 
endothelial cells, we isolated endothelial cells using magnetic beads (see Methods). Our data 
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shows that at the protein level, Hlx is robustly upregulated in endothelial cells at the 14-somite 
stage (Figure 2E). Expression then plateaus at mid- vascular remodeling stage (20 somites) and 
mature remodeled stage (4 days, or Hamburger Hamilton stage 23). Therefore, Hlx is 
upregulated in the capillary plexus at the 14-somite stage, which coincides with the onset of 
blood circulation.  
 
Hlx regulates endothelial sprouting in vitro 
To examine Hlx regulation and function in sprouting angiogenesis, we tested Hlx 
expression levels in HUVECs stimulated with VEGF or sDLL4 and BMP9, which promote tip and 
stalk cell fate, respectively. A 24-hour stimulation of VEGF induced an eight-fold increase in the 
expression of Hlx (Figure 3A), while sDll4 and BMP9 both led to a reduction in Hlx expression 
(Figure 3B). We then asked whether Hlx loss-of-function affects downstream expression of tip 
and stalk cell genes. siRNA-mediated knockdown of Hlx (Figure 3C, 75% knockdown efficiency) 
reduced expression of some tip cell-enriched genes including Esm1 and Dll4 but expression of 
Unc5B, Nidogen-2, Apln, Ang2, PDGFB and uPAR was not affected by Hlx knockdown (Figure 
3D). Furthermore, Hlx knockdown failed to increase expression of stalk cell genes Ets1, Tie2 and 
Jag1 (Figure 3E). These data suggest that Hlx affects expression of some, but not all, tip cell 
genes. To further investigate the role of Hlx in sprouting angiogenesis, we used an in vitro 
sprouting assay with HUVECs embedded in 3D-fibrin gels 14. siRNA-mediated knockdown of Hlx 
significantly reduced VEGF-induced endothelial sprouting (Figure 3F). Taken together, these 
results suggest that Hlx expression regulates the expression of only a few tip cell genes, but that 
it does influence sprouting angiogenesis in vitro. 
 
Hlx expression is regulated by flow and shear stress levels in vivo and in vitro 
Given that we saw a significant increase in Hlx expression in endothelial cells at the onset 
of circulation, we next investigated whether blood flow regulated Hlx expression. To test this, we 
performed loss-of-flow (LOF) and gain-of-flow (GOF) experiments in quail embryos. For LOF, we 
ablated flow by snipping the inlet to the heart at 8 somites and allowed the embryo to develop 
until 18 somites, which results in embryos with no cardiac output and arrested vascular 
remodeling15. The expression of Hlx in the absence of flow was then determined by Western blot 
analysis of whole embryo lysates. We found that Hlx expression is significantly decreased in 
embryos lacking blood flow when compared to stage-matched controls (Figure 4A).  
Blood flow creates a mechanical force on endothelial cells called shear stress, which is a 
function of fluid viscosity, flow rate and vessel diameter. Thus, by increasing the viscosity of 
blood one can increase the shear stress in the circulation without affecting flow velocity. 
Therefore, for the GOF experiments, we increased shear stress levels in the circulation of 
embryos by microinjecting a viscous starch solution at the 14-somite stage, using a method we 
previously developed 16. Hlx protein expression was analyzed 6 hours post injection, and found 
to be significantly increased in embryos with increased shear stress (Figure 4B). Densitometric 
analysis confirms significant up-regulation of Hlx in embryos in the vascular system in which we 
altered blood viscosity. These data suggest that Hlx expression is not only endogenously 
upregulated at the onset of blood circulation, but also affected by manipulating patterns of flow in 
the embryo.  
We further investigated the possibility that changes in shear stress can affect Hlx 
expression in an in vitro system. We exposed cultured human abdominal aortic endothelial cells 
(HAAEC) to flow using a parallel plate flow chamber. HAAEC were seeded on a microscope 
slide, placed in a parallel plate flow chamber and exposed to low levels of laminar flow (5 
dyn/cm2) for 1 hour. These levels are similar to the level of shear stress present at the onset of 
circulation 17. Our data shows that in cultured endothelial cells, Hlx RNA expression is 
significantly upregulated by steady embryonic-like flow compared to control static conditions 
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(Figure 4C). Western blot confirms that Hlx protein expression is upregulated in endothelial cells 
stimulated with embryonic laminar flow for 6 hours (Figure 4C). 
 
Hlx-/- embryos show normal angiogenic sprouting but defective yolk sac vascular 
remodeling 
To determine if Hlx function was required for angiogenic sprouting and/or yolk sac 
vascular remodeling in vivo, we next examined vascular development in Hlx-/- mouse embryos 4. 
Intraembryonic vascular development appeared to occur normally in these embryos. At E8.5, the 
dorsal aorta and heart had formed normally (Figure 5A). At E9.5, intersomitic vessels sprout 
from the dorsal aorta and fuse to form the dorsal vein. No difference was observed between 
control or knockout embryos (Figure 5B). Formation of the branchial arch arteries was also 
phenotypically normal as was cranial vascularization. Staining for Endomucin also did not reveal 
any differences in the vasculature of the embryo at E9.5 between heterozygous and knockout 
littermates (Figure 5C). 
Though intra-embryonic sprouting angiogenesis was normal, we next looked at vascular 
remodeling in the yolk sac of Hlx-null embryos. The yolk sac capillary plexus forms as an 
immature plexus that undergoes remodeling between E8.5 and E9.5. We found no defects in the 
capillary plexus of Hlx-/- embryos at E8.5, before the onset of flow (data not shown). At E9.5, Hlx-
/- yolk sacs had undergone vascular remodeling and were not grossly affected by ablation of Hlx 
as compared to control (Figure 5D). However, closer inspection of the remodeled E9.5 vascular 
plexus showed defects in the conformation of the arterial and venous plexus. To quantify the 
morphological differences in the Hlx+/- and Hlx-/- vascular plexus, we measured lumen diameter 
of the veins and arteries; the surface area with arterial versus venous morphology; the alignment 
of arterial endothelial cells with the direction of blood flow; the endothelial cell shape index and 
the density of branchpoints in the arterial and venous plexus. Among these morphometric 
measurements, the surface area of the Hlx-/- venous plexus and the diameter of the vitelline vein 
and artery were significantly different when compared to controls. Specifically, the venous plexus 
occupies a larger percentage of the vascularized yolk sac than in wild-type embryos (Figure 5D, 
E). The vitelline artery tree is reduced in size and the vitelline vein is increased in diameter 
(Figure 5E). Additionally, we investigated arterial-venous identity and found normal expression of 
Cx40, an arterial-specific marker, in the Hlx-/- vascular plexus (Figure 5F), suggesting that 
induction of arterial gene expression is unaffected. 
We next evaluated Hlx deficient embryos at E11.5 through hematoxylin and eosin 
staining on sections. As previously reported4, we found that the liver completely failed to form in 
Hlx-null embryos (Figure 6A,B, arrow). Though the intestine formed, its development was 
significantly retarded (Figure 6A,B). 
Examination of vascular development at this stage by CD31 staining of transverse 
sections through the embryo showed no defect in the dorsal aorta or its branches (Figure 6C). 
Smooth muscle cells were present around the dorsal aorta and no differences were observed in 
the thickness of the smooth muscle cell layer (Figure 6D). On longitudinal sections through the 
embryo, both intersomitic arteries and veins appeared normal (Figure 6E). The embryonic 
hindbrain is vascularized by angiogenic sprouting between E10.5 and E11.5, therefore we 
measured vascular density at E11.5 in Hlx+/+and Hlx-/- hindbrain wholemounts (Figure 6F). 
Quantification of branchpoint density showed no difference between wild-type embryos and Hlx-/- 
embryos. Therefore, the remodeling defect that occurred in the yolk sac at E.9.5 did not lead to 
detectable intraembryonic vascular defects by E11.5, suggesting that Hlx modulates vessel 
remodeling but is dispensable for angiogenic sprouting in mice.  
 
DISCUSSION 
In zebrafish embryos, Hlx expression has been shown to be dynamically regulated during 
sprouting angiogenesis, with initial tip-cell selective expression that subsequently becomes 
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restricted to stalk cells and is absent from other embryonic endothelial cells 11. We show here 
that Hlx is also expressed in subsets of sprouting vessels in mouse embryos in vivo, including tip 
cells in the developing retina. We had previously performed microarray comparison between 
wildtype and Dll4+/- retinal endothelial cells and found Hlx to be upregulated in the Dll4+/- 
population.  Furthermore, we show that in cultured human endothelial cells, Notch activation by 
Dll4 decreases Hlx expression, while VEGF increases it, as reported previously 10. These data, 
together with other reports10, 11, show that Hlx regulation by VEGF and Notch signaling is 
conserved between zebrafish, mouse and human endothelial cells. Overexpression of Hlx in 
cultured endothelial cells had previously been shown to inhibit angiogenic sprouting through 
upregulation of guidance receptors including the repulsive Netrin receptor UNC5B 10, 18. Here we 
show that knockdown of Hlx also inhibits endothelial sprouting in vitro, indicating that both loss-
and gain of Hlx function affect in vitro sprouting. In line with these observations, Hlx knockdown 
in zebrafish embryos led to decreased intersomitic vessel formation, indicating functional 
requirement of Hlx for angiogenic sprouting in this species in vivo 11. In contrast, we show here 
that sprouting angiogenesis occurs normally in mouse embryos deficient for Hlx. Hlx-/- embryos 
die during mid-gestation because of severe anemia due to defective liver development 4. 
Analysis of vessel development in embryos between E8.5 and E11.5 failed to reveal any obvious 
defects in formation of major vessels such as the dorsal aorta and cardinal vein or their side 
branches. Thus, in contrast to the in vitro setting and zebrafish in vivo data10, 11, loss of Hlx in the 
mouse embryo does not affect sprouting angiogenesis. This is in agreement with the in situ 
hybridization results, which show that Hlx is expressed in only a subset of sprouting vessels. 
Furthermore, our in vitro experiments show that most tip and stalk cell genes are unaffected by 
Hlx knockdown. Therefore, we have been unable to confirm a role for Hlx in sprouting 
angiogenesis in the mouse embryo. Although we cannot exclude the possibility that minor 
phenotypes may have been missed, our results indicate that Hlx is dispensable for sprouting in 
mouse embryos. Inducible, endothelial specific Hlx knockout may reveal a role for Hlx in 
sprouting in other tissue beds and/or at later stages of development or in pathology. 
In addition to expression in tip cells and sprouting vessels, we found that endothelial-
specific Hlx expression was increased at the onset of circulation. We confirmed that blood flow 
and more specifically shear stress was responsible for the increase in Hlx expression using 3 
different models: 1) by ablating flow in the embryo, 2) by increasing shear stress in the 
embryonic circulation and 3) by exposing human endothelial cells to shear stress in vitro. All 
three models confirmed that Hlx is upregulated in response to steady laminar type flow. In vivo, 
we observed a yolk sac remodeling defect after the onset of extraembryonic blood flow, 
suggesting that blood flow is a physiological signal for Hlx regulation and that Hlx is required for 
vessel remodeling. The defect in remodeling may be a direct cause of the defective shear-
induced signaling pathways, but this remains to be definitively proven. In the intestine, 
expression of Hlx by mesenchymal cells has been shown to direct neural crest cell migration3.  
Given that we observe Hlx expression in mesodermal cells of the yolk sac, we cannot exclude 
the possibility that factors expressed by non-endothelial cells are driving the remodeling 
phenotype. Though the relative balance of arteries and veins is altered in the knockout embryos, 
it is important to note that expression of arterial-specific gene is unaffected in the Hlx-/- vascular 
plexus, as shown by Cx40 staining. Signals from shear stress are transduced through the VEGF 
receptor VEGFR2 19, suggesting that Hlx may be induced downstream of VEGFR2 signaling in 
both angiogenic sprouts and perfused embryonic blood vessels. Whether shear-induced 
expression of Hlx has an effect on angiogenic sprouting, however, is unclear. 
Using adenoviral constructs to upregulate recombinant Hlx, Testori et al. showed that Hlx 
expression induces an upregulation of Notch targets including Unc5B, PlexinA1, Sema3G and 
Hes1 10. Unc5B 20, Sema3G 21 and Hes1 22 all display arterial specific expression patterns. 
Interestingly, the endothelial specific double-mutant of Hes1/Hes5 shows a very comparable 
phenotype to the Hlx-/- mutants 22
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such that the diameter of vessels branching off the main carotid artery is decreased, but no 
change in the diameter of the major arteries themselves is observed. The authors did not 
investigate the venous vasculature. Given that Hlx ablation results in a similar phenotype to 
Hes1/5 ablation, we propose that Hlx is upstream of Hes1 in the process of vascular remodeling.  
The promoter of Hlx shows a significant number of shear-response elements (SSRE) 
previously shown to regulate shear response in gene promoters. In silico analysis of the aligned 
mouse and human Hlx promoters revealed the presence of 28 different transcription factor 
binding sites and cis-acting elements conserved on the promoter, which have been previously 
shown to regulate shear response in other gene promoters.  It is important to note that the 
transcriptional responsiveness to shear stress is determined by a combination of SSRE rather 
than by a single SSRE. Most notably, two inverted CCAAT motifs are found in the Hlx promoter, 
which were previously identified to be functionally important for Hlx expression 23. The CCAAT 
motif binds CCAAT-enhancer-binding proteins (C-EBP), and has been identified as a positive 
and robust SSRE 24. Furthermore, two KLF2 binding sites (2 CACCC boxes, located within 50bp 
of start site) are located proximal to the mouse and human Hlx start site. Expression of KLF2 
regulates many shear-expressed genes 25, 26.  Given the conserved presence of multiple shear 
stress response elements on the mouse and human Hlx promoters, including the well-
characterized KLF2, we propose that Hlx is upregulated in response to shear stress by shear-
sensitive transcription factors; and that it is a downstream effector of mechanotransduction 
rather than a primary transcription factor required for mechanosensitive gene induction.  
Though our finding shows that Hlx is required for normal yolk sac vascular remodeling at 
E9.5, this defect does not lead to apparent major intra-embryonic vessel remodeling defects at 
E11.5. We did not pursue analysis of potential flow-induced phenotypes later in development 
since flow-induced defects cannot be differentiated from defects in hematopoiesis seen in Hlx-/- 
embryos. Primitive hematopoiesis, which begins in the yolk sac at E7.5, migrates to the 
embryonic liver at E10.5, where the secondary site of hematopoeisis takes place. The Hlx-null 
embryos fail to form a liver and are anemic by E13.5 4, inevitably resulting in a decreased 
hematocrit due to reduced hematopoietic cell population. Shear stress is a function of both rate 
of blood flow but also the viscosity of the blood.  The hematocrit is the primary determinant of 
blood viscosity.  As such, as the Hlx-/- embryos become anemic by E13.5, the shear stress levels 
also decrease. In order to study the effects of Hlx on flow-induced remodeling in the vasculature 
independently of liver defects, an endothelial-specific deletion of Hlx would be necessary. 
Taken together, our results show that Hlx expression is conserved in a subset of 
developing blood vessels in mouse and avian embryos and indicate that its expression in 
developing blood vessels is dynamically regulated.  Our in vitro results show that Hlx expression 
can be controlled both by signals for sprouting and by shear stress.  Our in vivo results show that 
the role of Hlx in sprouting is non-essential.  Hlx-null embryos do show a defect in vascular 
remodeling in which patterning is abnormal. 
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SIGNIFICANCE 
Identifying the genes that control sprouting angiogenesis are of vital importance to targeting the 
angiogenic process. Certain signals induce endothelial cells to become “leader cell”, or tip cells, 
during sprouting whereas other signals induce cells to become trailing cells or “stalk cells”.  Hlx 
has recently been suggested to be an important regulator of stalk cell identity and to balance 
attractive guidance cues during sprouting.  Our in vitro results agree with this role. In vivo, 
however, Hlx null embryos lack a sprouting phenotype.  We did, however, find that Hlx is 
upregulated in vivo at the stage where blood flow begins.  Using gain- and loss-of-function 
experiments, we found that Hlx expression is regulated by flow. When we investigate vascular 
remodeling in the embryo, we find abnormal patterning.  The shear-induced expression of Hlx in 
endothelial cells is completely novel, which has previously only been associated only with 
sprouting angiogenesis.  
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Figure 1 –Hlx is expressed in some but not all sprouting vessels. Hlx expression in P5 
mouse retinas is enriched in a subset of tip cells (tip cells positive for Hlx; red arrowheads and 
tip cells negative for Hlx; blue arrowheads, A-B). Sections of E10.5 embryos shows expression 
in the splanchnic mesoderm (C) associated with the developing liver (Li) and lung (L) but absent 
from heart (Hrt). Sense probes were produced as control (D). Expression is absent in the 
endothelium of the aorta (Ao, E) but present in vessels sprouting off the aorta (black arrowhead). 
The strongest expression is seen in the developing intestine (Int, E). Hlx is also expressed in the 
vascular plexus surrounding the neural tube (Nt) (F, arrows) but absent in endothelial cells 
sprouting into the neural epithelium (G, H, green arrowheads).  Sections in G,H are higher 
magnifications of a region of neural epithelium equivalent to the region boxed in F. Sections 
were counterstained with anti-Coll IV antibody (G). Scale bars: 50 µm (A, B) ; 1000 µm (C, D); 
50 µm (E, F); 20 µm (G,H).  
 
Figure 2 – Hlx is upregulated at the onset of blood flow. In situ analysis of 14 (A) and 20 
somite-stage (B) quail embryo shows intraembryonic expression is confined to the splanchnic 
mesoderm and the branchial arches (arrowheads). No expression in the dorsal aorta or heart is 
observed. Wholemount in situ analysis shows that Hlx expression is observed in the yolk sac at 
8 somites (before blood circulation), at 14 somites (onset of circulation), and at 20 somites (C). 
Sense probe was produced as control (D). Endothelial cells were isolated from pools of whole 
quail embryo lysates and analyzed for endogenous Hlx protein expression (E). Hlx protein 
expression in endothelial cells peaks at 14 somites following the onset of blood flow in the 
embryo; and plateaus at 20 somites and at 4 days of development. Protein loading was 
assessed by Coomassie staining (bottom panel). Densitometric analysis confirms significant up-
regulation of Hlx at 14 somites, when normalized to 7 somites (n=3 samples per stage, between 
3 and 25 embryos per sample depending on stage). All values are mean ± SEM. *p < 0.05; **p < 
0.01; two-tailed Student’s t-test. Scale bars: 500 µm (A, B); 200 µm (C, D). 
 
 
Figure 3 – Hlx knockdown regulates sprouting in vitro. Stimulation of endothelial cells with 
VEGF caused a significant increase in Hlx expression (n=8, A) whereas stimulation with BMP9 
and Dll4 significantly decreased Hlx mRNA levels (n=3, B). Using siRNA against Hlx, we achieve 
a 75% knockdown (n=5, C). Two of eight tip cell markers were significantly downregulated by 
knockdown of Hlx (n=3 to 5, D). Of the three stalk cell markers investigated, only jagged1 
expression was increased, albeit not significantly (n=3, E). Knockdown of Hlx also caused a 50% 
reduction in the ability of endothelial cells to form tubes in fibrin gel (n=3, F). All values are mean 
± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; two-tailed Student’s t-test. Scale bars: 100 µm (F). 
 
Figure 4 – Shear stress regulates Hlx expression levels. For the loss-of function 
experiments, flow was ablated at 8 somites in quail embryos and Hlx protein levels were 
assessed at 18 somites. Hlx expression is downregulated when blood flow is ablated, as 
compared to age-matched controls (A, n=3, 3-6 embryos per sample). Protein loading was 
assessed by Coomassie staining (bottom panel). For the gain of function experiments, quail 
embryos were injected with a starch solution at 14 somites and Hlx protein levels were assessed 
at 22 somites. Hlx is upregulated when blood viscosity is increased compared to age-matched 
controls (B, n=3 with 3-6 embryos per sample). Western Blot analysis of human endothelial cells 
exposed to laminar flow for 6 hours (5 dyn/cm2) confirms that Hlx protein expression is 
upregulated by shear stress (n=3, C). Hlx RNA levels were also increased by simulating 
HAAECs to laminar flow for 1h (n=6). All values are mean ± SEM. ∗p < 0.05; ∗∗∗p < 0.001; two-
tailed Student’s t-test. 
 
	  	   13	  
Figure 5 – Remodeling defects are present in the Hlx-/- embryo. CD31 staining of endothelial 
cells at E8.5 shows no detectable difference between Hlx+/+ and Hlx-/- embryos (A). At E9.5, Hlx-/- 
embryo proper also shows normal vascular development and intersomitic sprouting compared to 
Hlx+/- embryos (B). Higher magnification images of embryos stained for Endomucin also failed to 
identify any defects in intersomitic sprouting (C). In the capillary plexus of the yolk sac, the 
venous plexus (V) occupies a slightly larger fraction of the vascular plexus than the arterial 
region (A) in Hlx-/- embryos as compared to heterozygous littermates (D). Quantification of the 
surface area with arterial versus venous morphology confirms these differences (n=9 for Hlx+/- 
and n=5 for Hlx-/-, E). The diameter of the vitelline artery and vein were also significantly different 
between Hlx+/- and Hlx-/- embryos (E). Staining for Cx40 showed that arterial differentiation was 
normal (F). Scale bars: 1000 µm (A, B, D); 200 µm (C) and 300 µm (F). All values are mean ± 
SEM. ∗p < 0.05; ∗∗p < 0.01; two-tailed Student’s t-test. 
 
Figure 6 – Vascular development is normal in Hlx-/- embryos at E11.5. The lung (Lu), liver 
(Li) and intestine (In) form normally in wild-type embryos (A), but in Hlx-/- embryos the liver fails 
to form (arrow) and the intestine is abnormal (B). CD31 staining on sections shows that the aorta 
(Ao) and cardinal vein (CV) are similar in wild type and knock-out embryos (C). Alpha-smooth 
actin staining also showed normal development of smooth muscle around cardinal vein, aorta 
and aorta branches (arrows, D). Both intersomitic arteries (black arrows) and veins (red arrows) 
are normal (E). Quantification of branch points in isolectinB4-stained E11.5 hindbrain 
wholemounts showed no change in density in knock-out embryos as compared to wild-type 
littermate controls (n = 4-5 embryos, F). All values are mean ± SEM. Scale bars: 500 µm (A-B), 
100 µm (C,D,E) and 200 µm (F). 
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